Related Experiment Video

Updated: Jul 4, 2025

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
06:49

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians

Published on: March 14, 2014

11.6K

IADVL SIG Recalcitrant Dermatophytosis Position Statement on Super Bioavailable Itraconazole

Nayankumar H Patel1, Kabir Sardana2, Manjunath M Shenoy3

  • 1Department of DVL, GCS Medical College Hospital and Research Centre, Ahmedabad, Gujarat, India.

Indian Dermatology Online Journal
|January 29, 2024
PubMed

Insights

Super bioavailable itraconaconazole (SUBA-ITZ) offers improved pharmacokinetics for treating recalcitrant dermatophytosis (RD). This position statement guides dermatologists on effectively and safely using SUBA-ITZ for RD management.

Area of Science:

  • Dermatology
  • Pharmacology
  • Mycology

Background:

  • Itraconazole (ITZ) is a primary oral antifungal for recalcitrant dermatophytosis (RD) in India.
  • A new super bioavailable formulation (SUBA-ITZ) is now available.
  • Understanding SUBA-ITZ pharmacokinetics is crucial for safe and effective clinical use.

Purpose of the Study:

  • To review current evidence on SUBA-ITZ.
  • To establish the position of SUBA-ITZ in managing RD.
  • To guide dermatologists on SUBA-ITZ utilization.

Main Methods:

  • Position statement development by the Special Interest Group for Recalcitrant Dermatophytosis (SIG-RD).
  • Review of existing scientific literature and clinical data on SUBA-ITZ.
  • Expert consensus and formulation of recommendations.

Main Results:

  • SUBA-ITZ demonstrates enhanced bioavailability compared to conventional ITZ formulations.
  • Pharmacokinetic data supports potentially improved efficacy and safety profiles.
  • The SIG-RD provides guidance on integrating SUBA-ITZ into RD treatment protocols.

Conclusions:

  • SUBA-ITZ represents a significant advancement in oral antifungal therapy for RD.
  • Dermatologists should consider SUBA-ITZ for improved patient outcomes in RD.
  • Further research may elucidate long-term efficacy and safety of SUBA-ITZ.
Keywords:
DermatophytosisSUBA itraconazoleposition paper

More Related Videos

Identification of Small Molecule-binding Proteins in a Native Cellular Environment by Live-cell Photoaffinity Labeling10:49

Identification of Small Molecule-binding Proteins in a Native Cellular Environment by Live-cell Photoaffinity Labeling

Published on: September 20, 2016

12.7K
A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms06:50

A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms

Published on: September 16, 2022

3.1K

Related Concept Videos

Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
3.9K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
166
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
120